Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
27.43
-2.63 (-8.75%)
At close: Jan 16, 2026, 4:00 PM EST
27.25
-0.18 (-0.66%)
After-hours: Jan 16, 2026, 7:58 PM EST
RGC Market Cap
RGC has a market cap or net worth of $13.56 billion as of January 16, 2026. Its market cap has increased by 21,525.33% in one year.
Market Cap
13.56B
Enterprise Value
13.56B
1-Year Change
21,525.33%
Ranking
Category
Stock Price
$27.43
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $13.56B, an increase of 11,193.78%. That is a compound annual growth rate of 185.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 14.86B | 43.14% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 954.30B |
| Johnson & Johnson | 518.53B |
| AbbVie | 393.08B |
| UnitedHealth Group | 304.64B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.93B |
| Novo Nordisk | 265.30B |